Follow
David F. Condon
David F. Condon
Verified email at stanford.edu
Title
Cited by
Cited by
Year
The 6th World Symposium on Pulmonary Hypertension: what’s old is new
DF Condon, NP Nickel, R Anderson, S Mirza, VA de Jesus Perez
F1000Research 8, 2019
1492019
Phenyl-α-tert-butyl-nitrone and benzonidazole treatment controlled the mitochondrial oxidative stress and evolution of cardiomyopathy in chronic chagasic rats
JJ Wen, S Gupta, Z Guan, M Dhiman, D Condon, C Lui, NJ Garg
Journal of the American College of Cardiology 55 (22), 2499-2508, 2010
972010
Diagnosis and management of pulmonary hypertension in the modern era: insights from the 6th world symposium
CA Thomas, RJ Anderson, DF Condon, VA de Jesus Perez
Pulmonary therapy 6 (1), 9-22, 2020
622020
Leishmania major inhibits IL‐12 in macrophages by signalling through CR3 (CD11b/CD18) and down‐regulation of ETS‐mediated transcription
C Ricardo‐Carter, M Favila, RE Polando, RN Cotton, K Bogard Horner, ...
Parasite immunology 35 (12), 409-420, 2013
512013
Mural cell SDF1 signaling is associated with the pathogenesis of pulmonary arterial hypertension
K Yuan, Y Liu, Y Zhang, A Nathan, W Tian, J Yu, AJ Sweatt, ...
American journal of respiratory cell and molecular biology 62 (6), 747-759, 2020
422020
Human dendritic cells exhibit a pronounced type I IFN signature following Leishmania major infection that is required for IL-12 induction
MA Favila, NS Geraci, E Zeng, B Harker, D Condon, RN Cotton, ...
The Journal of Immunology 192 (12), 5863-5872, 2014
412014
Lung Pericytes in Pulmonary Vascular Physiology and Pathophysiology
K Yuan, S Agarwal, A Chakraborty, DF Condon, H Patel, S Zhang, ...
Comprehensive Physiology 11 (3), 2227-2247, 2011
382011
NOVEL MECHANISMS TARGETED BY DRUG TRIALS IN PULMONARY ARTERIAL HYPERTENSION
DF Condon, S Agarwal, A Chakraborty, N Auer, R Vazquez, H Patel, ...
Chest, 2021
352021
Novel TNIP2 and TRAF2 Variants Are Implicated in the Pathogenesis of Pulmonary Arterial Hypertension
S Pienkos, N Gallego, DF Condon, A Cruz-Utrilla, N Ochoa, J Nevado, ...
Frontiers in medicine 8, 2021
142021
From 2D to 3D: promising advances in imaging lung structure
T Klouda, D Condon, Y Hao, W Tian, M Lvova, A Chakraborty, MR Nicolls, ...
Frontiers in Medicine 7, 343, 2020
102020
The cancer hypothesis of pulmonary arterial hypertension: the next ten years
D Condon, S Agarwal, A Chakraborty, VA de Jesus Perez
American Journal of Physiology-Lung Cellular and Molecular Physiology 318 (6 …, 2020
82020
Anatomic, genetic and functional properties of the retinal circulation in pulmonary hypertension
NP Nickel, EA Shamskhou, MA Razeen, DF Condon, ...
Pulmonary circulation 10 (2), 2045894020905508, 2020
72020
CES1 Deficiency is Associated With Oxidative Stress and Endoplasmic Reticulum/Mitochondrial Injury in Pulmonary Endothelial Cells
S Agarwal, A Chakraborty, D Condon, E Shamskhou, H Patel, L Liu, ...
Circulation 144 (Suppl_1), A14101-A14101, 2021
2021
Novel variants in ABIN2 and TRAF2 implicated in pathogenesis of pulmonary arterial hypertension
N Gallego, D Condon, S Pienkos, V Perez, I Hernandez, C Perez-Olivares, ...
EUROPEAN JOURNAL OF HUMAN GENETICS 28 (SUPPL 1), 283-283, 2020
2020
Vascular Inflammation in Pulmonary Hypertension is Exacerbated by Litaf-dependent Pericyte Signaling
D Condon, K Shamskhou, A Nathan, A Sweatt, A Chakraborty, S Agarwal, ...
Circulation 142 (Suppl_3), A15053-A15053, 2020
2020
The Yin-yang of Bmpr2 and Ces1 in the Pulmonary Endothelium Aad Its Role in Pulmonary Arterial Hypertension
S Agarwal, A Chakraborty, D Condon, S Tello, K Suresh, BD Hammock, ...
Circulation 142 (Suppl_3), A15092-A15092, 2020
2020
Litaf-Dependent Pericyte Signaling Perpetuates Vascular Inflammation in Pulmonary Hypertension
DF Condon, K Shamskhou, A Nathan, A Sweatt, A Chakraborty, ...
D96. WHAT'S NEW IN PAH AND RV SIGNALING: LESSONS FROM THE BEST ABSTRACTS …, 2020
2020
Cxcl12 Activation Induces Pericyte Dissociation and Small Vessel Loss in PAH
K Yuan, V de Jesus Perez, Y Liu, A Nathan, D Condon, S Zhang
Circulation 140 (Suppl_1), A13054-A13054, 2019
2019
Miliary Tuberculosis In An IGRA Negative Patient After Adalimumab Treatment: A Case Report And Literature Review
DF Condon, T Cheng, J Bernardo
B50. TUBERCULOSIS: CASE REPORTS, A3778-A3778, 2016
2016
B50 TUBERCULOSIS: CASE REPORTS: Miliary Tuberculosis In An Igra Negative Patient After Adalimumab Treatment: A Case Report And Literature Review
DF Condon, T Cheng, J Bernardo
American Journal of Respiratory and Critical Care Medicine 193, 1, 2016
2016
The system can't perform the operation now. Try again later.
Articles 1–20